Zheman Xiao Selected Research

Zheman Xiao Research Topics

Disease

6	Migraine Disorders (Migraine) 10/2022 - 07/2013
4	Guillain-Barre Syndrome 02/2022 - 01/2018
4	Major Depressive Disorder (Major Depressive Disorders) 01/2013 - 03/2007
3	Epilepsy (Aura) 10/2022 - 01/2017
3	Pain (Aches) 12/2020 - 01/2015
2	Hyperalgesia 07/2022 - 04/2022
1	Status Epilepticus (Complex Partial Status Epilepticus) 04/2022
1	Seizures (Absence Seizure) 04/2022
1	Diabetes Mellitus 02/2022
1	Cancer Pain 12/2020
1	Experimental Autoimmune Neuritis 12/2019
1	Muscular Diseases (Myopathy) 05/2019
1	Leukoencephalopathies 05/2019
1	Cognitive Dysfunction 05/2019
1	Febrile Seizures (Febrile Seizure) 10/2018
1	Respiratory Tract Infections (Respiratory Tract Infection) 01/2018
1	Schizophrenia (Dementia Praecox) 01/2018
1	Miller Fisher Syndrome (Fisher Syndrome) 01/2018
1	Infections 01/2018
1	Inflammation (Inflammations) 01/2018
1	Hypersensitivity (Allergy) 01/2018
1	Headache (Headaches) 01/2015
1	Migraine with Aura (Familial Hemiplegic Migraine) 03/2012
1	Neuralgia (Stump Neuralgia) 02/2008
1	Spinal Cord Injuries (Spinal Cord Injury) 02/2008

Drug/Important Bio-Agent (IBA)

3	Brain-Derived Neurotrophic Factor (BDNF)IBA 04/2022 - 01/2011
3	Amantadine (Aman)FDA LinkGeneric 02/2022 - 01/2018
2	Pilocarpine (Ocusert)FDA LinkGeneric 04/2022 - 01/2017
2	Proteins (Proteins, Gene)FDA Link 05/2019 - 01/2018
2	Antidepressive Agents (Antidepressants)IBA 01/2013 - 03/2007
2	Corticotropin-Releasing HormoneIBA 01/2013 - 03/2007
1	Purinergic P2X7 ReceptorsIBA 07/2022
1	Chemokine CX3CL1IBA 04/2022
1	Lithium ChlorideIBA 04/2022
1	AZD8797IBA 04/2022
1	GlucocorticoidsIBA 02/2022
1	Hemoglobins (Hemoglobin)IBA 02/2022
1	Glucose (Dextrose)FDA LinkGeneric 02/2022
1	Interleukin-18 (Interleukin 18)IBA 12/2020
1	CytokinesIBA 12/2019
1	Interleukin-17 (Interleukin 17)IBA 12/2019
1	Glucagon-Like Peptide 1 (GLP 1)IBA 10/2018
1	KN 93IBA 01/2018
1	SolutionsIBA 01/2018
1	Transient Receptor Potential ChannelsIBA 01/2018
1	syncytinIBA 01/2018
1	Viral ProteinsIBA 01/2018
1	Acid Sensing Ion ChannelsIBA 01/2018
1	Amiloride (Midamor)FDA LinkGeneric 01/2018
1	3- (4- t- butylphenyl)- N- (2,3- dihydrobenzo(b)(1,4)dioxin- 6- yl)acrylamideIBA 01/2018
1	AcidsIBA 01/2018
1	Calcium-Calmodulin-Dependent Protein Kinase Type 2IBA 01/2018
1	Calcitonin Gene-Related PeptideIBA 01/2017
1	salicylhydroxamic acid (SHAM)IBA 01/2017
1	Antiviral Agents (Antivirals)IBA 01/2015
1	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2015
1	Ion Channels (Ion Channel)IBA 07/2013
1	Calcium Channels (Calcium Channel)IBA 03/2012
1	Corticotropin-Releasing Hormone Receptors (Corticotropin Releasing-Hormone Receptor)IBA 01/2011
1	Glutamate Decarboxylase (Decarboxylase, Glutamate)IBA 02/2008
1	gamma-Aminobutyric Acid (GABA)IBA 02/2008

Therapy/Procedure

1	Duration of Therapy 10/2022
1	Intraperitoneal Injections 04/2022
1	Injections 04/2022
1	Artificial Respiration (Mechanical Ventilation) 02/2022
1	Length of Stay 01/2018
1	Therapeutics 01/2015